Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             106 results found
no title author magazine year volume issue page(s) type
1 Adaptogenic flower buds exert cancer preventive effects by enhancing the SCFA-producers, strengthening the epithelial tight junction complex and immune responses Xia, Wenrui

159 C p.
article
2 Age, sex, and specific gene mutations affect the effects of immune checkpoint inhibitors in colorectal cancer Lin, Anqi

159 C p.
article
3 AGK2 ameliorates mast cell-mediated allergic airway inflammation and fibrosis by inhibiting FcεRI/TGF-β signaling pathway Kim, Yeon-Yong

159 C p.
article
4 Angiotensin receptor blockers for the treatment of COVID-19 and its comorbidities Saavedra, Juan M.

159 C p.
article
5 An innovative method for screening and evaluating the degree of diabetic retinopathy and drug treatment based on artificial intelligence algorithms Xie, Qiwei

159 C p.
article
6 Antiproteinuric effect of DPP-IV inhibitors in diabetic and non-diabetic kidney diseases Nicotera, Ramona

159 C p.
article
7 Arctiin abrogates osteoclastogenesis and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation Chen, Delong

159 C p.
article
8 Artemisinin protects motoneurons against axotomy-induced apoptosis through activation of the PKA-Akt signaling pathway and promotes neural stem/progenitor cells differentiation into NeuN+ neurons Liu, Linlin

159 C p.
article
9 Artificial intelligence and network pharmacology based investigation of pharmacological mechanism and substance basis of Xiaokewan in treating diabetes Zhu, Chunyan

159 C p.
article
10 A specific gut microbiota and metabolomic profiles shifts related to antidiabetic action: The similar and complementary antidiabetic properties of type 3 resistant starch from Canna edulis and metformin Zhang, Chi

159 C p.
article
11 Beyond the limitation of targeted therapy: Improve the application of targeted drugs combining genomic data with machine learning Miao, Rui

159 C p.
article
12 Biochemical indicators of coronavirus disease 2019 exacerbation and the clinical implications An, Peng-jiao

159 C p.
article
13 Blame the signaling: Role of cAMP for the resolution of inflammation Tavares, Luciana P.

159 C p.
article
14 Bletilla striata oligosaccharides improve metabolic syndrome through modulation of gut microbiota and intestinal metabolites in high fat diet-fed mice Hu, Baifei

159 C p.
article
15 Chelidonine selectively inhibits the growth of gefitinib-resistant non-small cell lung cancer cells through the EGFR-AMPK pathway Xie, Ya-Jia

159 C p.
article
16 Chlorquinaldol targets the β-catenin and T-cell factor 4 complex and exerts anti-colorectal cancer activity Wang, Ling

159 C p.
article
17 Clinical approach to the inflammatory etiology of cardiovascular diseases Ruscica, Massimiliano

159 C p.
article
18 Clinical efficacy and predictors of response to dulaglutide in type-2 diabetes Berra, C.C.

159 C p.
article
19 Clinical impact of pre-admission antithrombotic therapy in hospitalized patients with COVID-19: A multicenter observational study Russo, Vincenzo

159 C p.
article
20 Controlling leukocyte trafficking in IBD Veny, Marisol

159 C p.
article
21 Corrigendum to “S1PR2 inhibitors potently reverse 5-FU resistance by downregulating DPD expression in colorectal cancer” [Pharmacol Res. 155 (2020) 104717] Zhang, Yu-Hang

159 C p.
article
22 Corrigendum to “The role of the LTB4-BLT1 axis in health and disease” [Pharmacol. Res. 158 (2020) 104857] He, Rui

159 C p.
article
23 COVID-19 and Kawasaki disease in children Xu, Suowen

159 C p.
article
24 Curcumin: an inflammasome silencer Hasanzadeh, Shima

159 C p.
article
25 Cutaneous endocannabinoid system: Does it have a role on skin wound healing bearing fibrosis? Correia-Sá, Inês

159 C p.
article
26 CXCR4 antagonist AMD3100 (plerixafor): From an impurity to a therapeutic agent Wang, Jingzhe

159 C p.
article
27 Databases for facilitating mechanistic investigations of traditional Chinese medicines against COVID-19 Jiang, Sida

159 C p.
article
28 Delivery routes for faecal microbiota transplants: Available, anticipated and aspired Gulati, Monica

159 C p.
article
29 Discovery of the FDA-approved drugs bexarotene, cetilistat, diiodohydroxyquinoline, and abiraterone as potential COVID-19 treatments with a robust two-tier screening system Yuan, Shuofeng

159 C p.
article
30 East meets West in COVID-19 therapeutics Wang, Shanshan

159 C p.
article
31 Editorial Board
159 C p.
article
32 Effect of Carbonic Anhydrase IX inhibitors on human endothelial cell survival Genah, Shirley

159 C p.
article
33 Efficacy and safety of HIF prolyl-hydroxylase inhibitor vs epoetin and darbepoetin for anemia in chronic kidney disease patients not undergoing dialysis: A network meta-analysis Zheng, Qiyan

159 C p.
article
34 Ephrin-Eph signaling usage by a variety of viruses de Boer, Esther C.W.

159 C p.
article
35 Epoxyeicosatrienoic acids: Emerging therapeutic agents for central post-stroke pain Wan, Li

159 C p.
article
36 Erinacine A and related cyathane diterpenoids: Molecular diversity and mechanisms underlying their neuroprotection and anticancer activities Bailly, Christian

159 C p.
article
37 Evodiamine has therapeutic efficacy in ulcerative colitis by increasing Lactobacillus acidophilus levels and acetate production Wang, Meng-Xia

159 C p.
article
38 Exploring the mechanism of TCM formulae in the treatment of different types of coronary heart disease by network pharmacology and machining learning Yang, Jian

159 C p.
article
39 Fecal bacteria can predict the efficacy of rifaximin in patients with diarrhea-predominant irritable bowel syndrome Li, Ying

159 C p.
article
40 First evidence of aryl hydrocarbon receptor as a druggable target in hypertension induced by chronic intermittent hypoxia Coelho, Nuno R.

159 C p.
article
41 Gap-134, a Connexin43 activator, prevents age-related development of ventricular fibrosis in Scn5a+/ − mice Patin, Justine

159 C p.
article
42 Genetics and epigenetics of IBD Annese, Vito

159 C p.
article
43 Global research on artemisinin and its derivatives: Perspectives from patents Liu, Kunmeng

159 C p.
article
44 Green tea improves the metabolism of peripheral tissues in β3-adrenergic receptor-knockout mice Sousa-Filho, Celso Pereira Batista

159 C p.
article
45 HBV induced hepatocellular carcinoma and related potential immunotherapy Jia, Liyang

159 C p.
article
46 Hypoxia-inducible factor-1α: A promising therapeutic target for vasculopathy in diabetic retinopathy Li, Hui-Yao

159 C p.
article
47 Indoleamine 2,3-dioxygenase in melanoma progression and BRAF inhibitor resistance Sandri, Silvana

159 C p.
article
48 Inflammatory bowel diseases, the hygiene hypothesis and the other side of the microbiota: Parasites and fungi Panelli, Simona

159 C p.
article
49 Innovative health risk assessment of heavy metals in Chinese herbal medicines based on extensive data Zuo, Tian-Tian

159 C p.
article
50 Interactions of antithrombotic herbal medicines with Western cardiovascular drugs Zuo, Hua-Li

159 C p.
article
51 Intermedin alleviates pathological cardiac remodeling by upregulating klotho Zhang, Lin-Shuang

159 C p.
article
52 LSD1 deletion represses gastric cancer migration by upregulating a novel miR-142-5p target protein CD9 Zhao, Li-Juan

159 C p.
article
53 Lycopene in protection against obesity and diabetes: A mechanistic review Zhu, Ruyuan

159 C p.
article
54 Lymecycline reverses acquired EGFR-TKI resistance in non–small-cell lung cancer by targeting GRB2 Chen, Yang

159 C p.
article
55 Mechanopharmacology of Rho-kinase antagonism in airway smooth muscle and potential new therapy for asthma Wang, Lu

159 C p.
article
56 Microbiota and cardiovascular disease risk: A scoping review Scarmozzino, Federico

159 C p.
article
57 Microbiota-derived butyrate regulates intestinal inflammation: Focus on inflammatory bowel disease Couto, Mafalda R.

159 C p.
article
58 Molecular mechanisms of hepatic insulin resistance in nonalcoholic fatty liver disease and potential treatment strategies Zhang, Chang-hua

159 C p.
article
59 Myo–inositol and d-chiro–inositol oral supplementation ameliorate cardiac dysfunction and remodeling in a mouse model of diet-induced obesity L’Abbate, Serena

159 C p.
article
60 Network pharmacological approach for elucidating the mechanisms of traditional Chinese medicine in treating COVID-19 patients Pan, Hu-Dan

159 C p.
article
61 Nose to brain drug delivery - A promising strategy for active components from herbal medicine for treating cerebral ischemia reperfusion Long, Yu

159 C p.
article
62 Nuclear Factor Kappa B in Autism Spectrum Disorder: A Systematic Review Liao, Xiaoli

159 C p.
article
63 Opioid receptors beyond pain control: The role in cancer pathology and the debated importance of their pharmacological modulation Carli, Marco

159 C p.
article
64 Opioid system influences gut-brain axis: Dysbiosis and related alterations Rueda-Ruzafa, Lola

159 C p.
article
65 Oroxylin A suppresses ACTN1 expression to inactivate cancer-associated fibroblasts and restrain breast cancer metastasis Cao, Yue

159 C p.
article
66 Pharmacological data of cannabidiol- and cannabigerol-type phytocannabinoids acting on cannabinoid CB1, CB2 and CB1/CB2 heteromer receptors Navarro, Gemma

159 C p.
article
67 Promising targets based on pattern recognition receptors for cancer immunotherapy Bai, Ling

159 C p.
article
68 Protein tyrosine phosphatase 1B inhibition as a potential therapeutic target for chronic wounds in diabetes Figueiredo, Ana

159 C p.
article
69 Proteotoxicity and mitochondrial dynamics in aging diabetic brain Fernandes, Valencia

159 C p.
article
70 Rimeporide as a first- in-class NHE-1 inhibitor: Results of a phase Ib trial in young patients with Duchenne Muscular Dystrophy Previtali, Stefano C.

159 C p.
article
71 Role of 5-HT receptors in neuropathic pain: potential therapeutic implications Liu, Qian Qian

159 C p.
article
72 Role of nitroxyl (HNO) in cardiovascular system: From biochemistry to pharmacology Sun, Hai-Jian

159 C p.
article
73 Rottlerin acts as a therapeutic in primary open-angle glaucoma by targeting the trabecular meshwork via activation of Rap1 signaling Zhu, Jingyi

159 C p.
article
74 S-allylmercaptocysteine inhibits mucin overexpression and inflammation via MAPKs and PI3K-Akt signaling pathways in acute respiratory distress syndrome An, Lulu

159 C p.
article
75 Searching for novel hydrogen sulfide donors: The vascular effects of two thiourea derivatives Citi, Valentina

159 C p.
article
76 Sestrin2 as a potential therapeutic target for cardiovascular diseases Gao, Anbo

159 C p.
article
77 Sirt3 is a novel target to treat sepsis induced myocardial dysfunction by acetylated modulation of critical enzymes within cardiac tricarboxylic acid cycle Xu, Yinchuan

159 C p.
article
78 Spermidine as a target for cancer therapy Fan, Jingjing

159 C p.
article
79 Statins and other drugs: Facing COVID-19 as a vascular disease Sanchis-Gomar, Fabian

159 C p.
article
80 SVCT2-Dependent plasma and mitochondrial membrane transport of ascorbic acid in differentiating myoblasts Fiorani, Mara

159 C p.
article
81 Targeting inflammation and cytokine storm in COVID-19 Huang, Qianwen

159 C p.
article
82 Targeting metabolic syndrome with phytochemicals: Focus on the role of molecular chaperones and hormesis in drug discovery Lakshmi, P.K.

159 C p.
article
83 Targeting T cells in inflammatory bowel disease Giuffrida, Paolo

159 C p.
article
84 Targeting the vascular endothelial growth factor receptor-1 by the monoclonal antibody D16F7 to increase the activity of immune checkpoint inhibitors against cutaneous melanoma Lacal, Pedro Miguel

159 C p.
article
85 Ternary complex factor regulates pancreatic islet size and blood glucose homeostasis in transgenic mice Lesch, Andrea

159 C p.
article
86 The ameliorating effects of anthocyanins on the cross-linked signaling pathways of cancer dysregulated metabolism Fakhri, Sajad

159 C p.
article
87 The Application of Ferroptosis in Diseases Qiu, Yangmin

159 C p.
article
88 The database-based strategy may overstate the potential effects of traditional Chinese medicine against COVID-19 Huang, Yu-Xi

159 C p.
article
89 The effect of voglibose on metabolic profiles in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of clinical trials Nowrouzi-Sohrabi, Peyman

159 C p.
article
90 The effects of ginsenosides on platelet aggregation and vascular intima in the treatment of cardiovascular diseases: From molecular mechanisms to clinical applications Luo, Bang-Yue

159 C p.
article
91 The effects of metformin administration on liver enzymes and body composition in non-diabetic patients with non-alcoholic fatty liver disease and/or non-alcoholic steatohepatitis: An up-to date systematic review and meta-analysis of randomized controlled trials Jalali, Mohammad

159 C p.
article
92 The efficacy and safety of ipriflavone in postmenopausal women with osteopenia or osteoporosis: A systematic review and meta-analysis Hu, Qinsheng

159 C p.
article
93 The flavonoid agathisflavone modulates the microglial neuroinflammatory response and enhances remyelination de Almeida, Monique Marylin Alves

159 C p.
article
94 The gut microbes, Enterococcus and Escherichia-Shigella, affect the responses of heart valve replacement patients to the anticoagulant warfarin Wang, Lin

159 C p.
article
95 The need for physiological phenotyping to develop new drugs for airways disease Chapman, David G

159 C p.
article
96 Therapeutic potential of genipin in various acute liver injury, fulminant hepatitis, NAFLD and other non-cancer liver diseases: More friend than foe Fan, Xiaofei

159 C p.
article
97 Therapeutic potential of pharmacological agents targeting TRP channels in CNS disorders Thapak, Pavan

159 C p.
article
98 The risk of hepatocellular carcinoma and aspirin use Liao, Kuan-Fu

159 C p.
article
99 Tissue-resident memory CD8+ T cells in cancer immunology and immunotherapy Wang, Ting

159 C p.
article
100 Treatment of dilated cardiomyopathy in a mouse model of Friedreich’s ataxia using N-acetylcysteine and identification of alterations in microRNA expression that could be involved in its pathogenesis Chiang, S.

159 C p.
article
101 Tumor-derived extracellular vesicles: Regulators of tumor microenvironment and the enlightenment in tumor therapy Chen, Jiming

159 C p.
article
102 Tumor microenvironment-related dendritic cell deficiency: a target to enhance tumor immunotherapy Zhu, Shan

159 C p.
article
103 What’s new in IBD therapy: An “omics network” approach Fiocchi, Claudio

159 C p.
article
104 Would ACEIs/ARBs be beneficial for COVID-19 patients without hypertension? Huang, Ying

159 C p.
article
105 Yes-associated protein and transcriptional coactivator with PDZ-binding motif as new targets in cardiovascular diseases Yu, Yue

159 C p.
article
106 ZLY032, the first-in-class dual FFA1/PPARδ agonist, improves glucolipid metabolism and alleviates hepatic fibrosis Li, Zheng

159 C p.
article
                             106 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands